Skip to main content
    C

    Corteva Inc (CTVA)

    Official site

    BASIC MATERIALS • AGRICULTURAL INPUTS • NYSE

    $9.04
    -0.39 (-4.14%)

    Market Cap: $6.29B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Corteva Inc (CTVA) Earnings: Report Dates and Results

    Updated Nov 11, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Corteva (CTVA) is expected to report earnings on Feb 1, 2027. In the quarter ended Sep 30, 2026, Corteva reported EPS of -$0.04, below the $0.09 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    84%(26/31)
    Avg Surprise
    +29.28%

    Upcoming Estimates

    Reports Feb 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.19
    Range$0.03 - $0.30
    19 analysts
    Revenue Consensus
    $2.26B
    Range$1.96B - $2.43B
    17 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.37
    Range$0.35 - $0.39
    3 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.39-6.0%
    Current$0.37
    Revenue Consensus
    $1.96B
    Range$1.95B - $1.96B
    2 analysts

    Next Report

    CTVA has an expected report date of Feb 1, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 13.6% below the $0.22 reported for the quarter ended Dec 31, 2025.

    CTVA Earnings Call

    The latest CTVA earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 31 quarters below that had an estimate, CTVA beat 26, missed 4 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.46B, down 6.1% from $2.62B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.04$0.09$0.00 - $0.18-144.44%MissN/A60 up, 0 downNov 11, 2026$2.46B
    Jun 30, 2026$2.30$2.24$2.18 - $2.33+2.68%Beat+4.5%150 up, 3 downJul 30, 2026$6.38B
    Mar 31, 2026$1.50$1.18$1.09 - $1.24+27.12%Beat+32.7%142 up, 1 downMay 5, 2026$4.91B
    Dec 31, 2025$0.22$0.22$0.19 - $0.280.00%In line-31.3%15N/AFeb 3, 2026$3.91B
    Sep 30, 2025-$0.23-$0.47-$0.54 - -$0.30+51.06%BeatN/A150 up, 5 downNov 4, 2025$2.62B
    Jun 30, 2025$2.20$1.88$1.75 - $1.95+17.02%Beat+20.2%159 up, 2 downAug 6, 2025$6.46B
    Mar 31, 2025$1.13$0.88$0.84 - $0.96+28.41%Beat+27.0%153 up, 2 downMay 7, 2025$4.42B
    Dec 31, 2024$0.32$0.31$0.24 - $0.45+3.23%Beat+113.3%151 up, 8 downFeb 5, 2025$3.98B
    Sep 30, 2024-$0.49-$0.30-$0.40 - -$0.23-63.33%MissN/A170 up, 0 downNov 6, 2024$2.33B
    Jun 30, 2024$1.83$1.72$1.58 - $1.86+6.40%Beat+14.4%160 up, 1 downJul 31, 2024$6.11B
    Mar 31, 2024$0.89$0.83$0.69 - $1.09+7.23%Beat-23.3%191 up, 0 downMay 1, 2024$4.49B
    Dec 31, 2023$0.15$0.06-$0.03 - $0.15+150.00%Beat-6.3%180 up, 1 downJan 31, 2024$3.71B
    Sep 30, 2023-$0.23-$0.26-$0.42 - -$0.07+11.54%BeatN/A182 up, 0 downNov 8, 2023$2.59B
    Jun 30, 2023$1.60$1.58N/A+1.27%Beat-2.4%191 up, 1 downAug 3, 2023$6.04B
    Mar 31, 2023$1.16$0.93$0.83 - $1.02+24.73%Beat+19.6%192 up, 0 downMay 3, 2023$4.88B
    Dec 31, 2022$0.16$0.06-$0.02 - $0.09+166.67%Beat+100.0%190 up, 1 downFeb 1, 2023$3.83B
    Sep 30, 2022-$0.12-$0.22-$0.30 - -$0.16+45.45%BeatN/A170 up, 0 downNov 3, 2022$2.78B
    Jun 30, 2022$1.64$1.46$1.40 - $1.58+12.33%Beat+17.1%182 up, 0 downAug 4, 2022$6.25B
    Mar 31, 2022$0.97$0.81$0.72 - $0.89+19.75%Beat+22.8%161 up, 1 downMay 4, 2022$4.60B
    Dec 31, 2021$0.08$0.09$0.01 - $0.18-11.11%Miss+100.0%171 up, 1 downFeb 2, 2022$3.48B
    Sep 30, 2021-$0.14-$0.31-$0.35 - -$0.26+54.84%BeatN/A17N/ANov 3, 2021$2.37B
    Jun 30, 2021$1.40$1.27$1.19 - $1.41+10.24%Beat+11.1%18N/AAug 5, 2021$5.63B
    Mar 31, 2021$0.79$0.65$0.54 - $0.75+21.54%Beat+33.9%18N/AMay 4, 2021$4.18B
    Dec 31, 2020$0.04-$0.04-$0.12 - $0.04+200.00%Beat-42.9%18N/AFeb 3, 2021$3.21B
    Sep 30, 2020-$0.39-$0.42-$0.50 - -$0.30+7.14%BeatN/A19N/ANov 4, 2020$1.86B
    Jun 30, 2020$1.26$1.24$0.98 - $1.46+1.61%Beat-11.3%20N/AAug 5, 2020$5.19B
    Mar 31, 2020$0.59$0.39$0.32 - $0.48+51.28%Beat+78.8%20N/AMay 6, 2020$3.96B
    Dec 31, 2019$0.07-$0.12-$0.14 - -$0.09+158.33%BeatN/A19N/AJan 30, 2020N/A
    Sep 30, 2019-$0.39-$0.45-$0.55 - -$0.35+13.33%Beat-135.5%18N/AOct 31, 2019$1.91B
    Jun 30, 2019$1.42$1.02$0.45 - $1.37+39.22%BeatN/A19N/AAug 1, 2019$5.56B
    Mar 31, 2019$0.33$0.35N/A-5.71%MissN/A1N/AMay 31, 2019$6.79B
    Dec 31, 2018-$0.15N/AN/AN/AN/AN/AN/AN/AMar 19, 2019N/A
    Sep 30, 2018$1.10N/AN/AN/AN/AN/AN/AN/AOct 18, 2018$3.89B
    Last 33 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $3.32, up 30.2% from the year before. It was $0.95 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$3.32+30.2%
    Dec 31, 2024$2.55-4.9%
    Dec 31, 2023$2.68N/A
    Dec 31, 2022$2.65+24.4%
    Dec 31, 2021$2.13+42.0%
    Dec 31, 2020$1.50+4.9%
    Dec 31, 2019$1.43+50.0%
    Dec 31, 2018$0.95N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 19 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,23519
    2026Q2Jun 30, 20267,00619
    2026Q1Mar 31, 20268,45019
    2025Q4Dec 31, 20258,45022
    2025Q3Sep 30, 20258,84022
    2025Q2Jun 30, 20258,02419
    2025Q1Mar 31, 20254,68215
    2024Q4Dec 31, 20248,57121

    2026Q3 Earnings Call

    Opening remarks

    Rafael Soares Head of Investor Relations Good morning, and welcome to Corteva's Third Quarter 2026 Earnings Conference Call. Our prepared remarks today will be led by Luke Kissam, Chief Executive Officer, and Jeff Rudolph, Chief Financial Officer. We have prepared presentation slides to supplement our remarks during this call, which are posted on the Investor Relations section of the Corteva website and through the link to our webcast. During this call, we'll make forward-looking statements, which are our expectations about the future. These statements are based upon current expectations and assumptions that are subject to various risks and uncertainties. Our actual results could materially differ from these statements due to these risks and uncertainties, including, but not limited to, those discussed on this call and in the Risk Factors section of our reports filed with the SEC. We do not undertake any duty to update any forward-looking statements. Please note, in today's presentation, we will be making reference to certain non-GAAP financial measures. EBITDA means adjusted pro forma operating EBITDA, and sales refers to pro forma net sales. Reconciliations of the non-GAAP measures can be found in our earnings press release and related schedules, along with our supplemental financial summary slide deck available on our Investor Relations website. It's now my pleasure to turn the call over to Luke.

    Luke Kissam CEO Thanks, Rafa, and good morning, everybody. Thanks for joining us. This is our first earnings call as a stand-alone company. So I want to start with the strategy we laid out at our recent Investor Day and how it played out in the quarter. In September, we said this chapter would be defined by innovation and execution. This quarter gave us clear proof points on both. The exception to that is Brazil, which I will unpack a bit more in a moment. Starting with innovation. New product volumes grew 20% in the quarter with growth in every region, and price was relatively stable for this group of products. Our business outside of Latin America performed roughly in line with expectations in a challenged operating environment. We generated growth across North America, EMEA and Asia Pacific. While pricing was down 12% in North America in the quarter, all of that headwind was caused by pricing actions related to acetochlor, which we forewarned at Investor Day. Productivity came in ahead of our expectations in the quarter, and we are on track to deliver our target for the year. We also brought SG&A spending down in the quarter as teams exercised good discipline on spend relative to our operating environment. And even as we took cost out, we increased our investment in R&D to keep advancing our pipeline, which is one of the real strengths of this company.

    Frequently Asked Questions About CTVA

    When is Corteva's next earnings date?

    Corteva's next earnings report is expected for Feb 1, 2027.

    Did CTVA beat earnings estimates last quarter?

    No. Corteva reported EPS of -$0.04 for the quarter ended Sep 30, 2026, below the $0.09 estimate by 144.44%.

    What EPS do analysts expect from CTVA next quarter?

    The consensus EPS estimate for Corteva for the quarter ending Dec 31, 2026 is $0.19 from 19 analysts, with estimates from $0.03 to $0.30.

    How often does CTVA beat earnings estimates?

    Corteva beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of -1.87%.